ImmunityBio Inc (NASDAQ: IBRX) is -1.95% lower on its value in year-to-date trading and has touched a low of $1.83 and a high of $9.16 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $2.36 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $2.51, the stock is 3.27% and -6.62% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.8 million and changing 6.36% at the moment leaves the stock -29.27% off its SMA200. IBRX registered -68.86% loss for a year compared to 6-month loss of -52.64%.
The stock witnessed a -4.56% gain in the last 1 month and extending the period to 3 months gives it a -20.82%, and is 24.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.28% over the week and 9.32% over the month.
ImmunityBio Inc (IBRX) has around 680 employees, a market worth around $2.22B and $31.22M in sales. Profit margin for the company is -1310.30%. Distance from 52-week low is 37.16% and -72.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-182.90%).
The EPS is expected to grow by 26.43% this year.
ImmunityBio Inc (IBRX) Top Institutional Holders
The shares outstanding are 853.39M, and float is at 91.81M with Short Float at 74.90%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0135% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6629 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1448% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5703 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
